Nice job. Your timing was perfect.
Sentiment: Strong Buy
Anyone know the answer to this? I'm not too concerned either way since epidiolex FDA approval is the key to this stock's success.
Risky move. There are additional Epidiolex phase 3 trials coming out in the 2nd half of this year. Positive results will send this stock higher.